Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|S1|S187-S194

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.S1, 2015-06, pp. : S187-S194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 6, 2009-12 ,pp. : 409-418

Karger

Access to resources Recommend Favorite

Role of Oral Factor Xa Inhibitors after Acute Coronary Syndrome

By  

Cardiology, Vol. 129, Iss. 4, 2014-11 ,pp. : 224-232

Karger

Access to resources Recommend Favorite

Evidence for the Use of Activated Prothrombin Complex Concentrates (aPCCs) in the Treatment of Patients with Haemophilia and Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 9-12

Karger

Access to resources Recommend Favorite

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2722-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite